The Patent Finder

Terms ending in 2032

Ardea Biosciences, Inc.

Every in-force patent on Ardea Biosciences, Inc.'s record whose computed term ends in 2032, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresConfidence
US 8,546,436Polymorphic Forms of 2-(5-Bromo-4-(4-Cyclopropylnaphthalen-1-YL)-4H-1,2,4-Triazol-3-Ylthio)ACETIC Acid and Uses Thereof
In force
 · High confidence
Ardea Biosciences, Inc.In forceHigh confidence
US 9,402,827Treatment of Gout
In force
 · High confidence
Ardea Biosciences, Inc.In forceHigh confidence
2 of 2 patents shown. Soonest term end first, then patent number.
Updated Nov 22, 2026 · includes USPTO assignment data published Nov 21, 2026, status data published Nov 22, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 22, 2026 · includes USPTO assignment data published Nov 21, 2026, status data published Nov 22, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited